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Pulmonary oedema after hexoprenaline
administration in preterm labour
A report of 4 cases
B. VAN IDDEKINGE, L. GOBETZ, P. G. R. SEAWARD, G. J. HOFMEYR
Summary
Despite the widespread use of ,a-sympathomimetic agents for
preterm labour there appears to be.a limited appreciation of
the need for cardiovascular monitoring in the mother. Four
patients in whom pulmonary oedema developed during
tocolysis with hexoprenaline are described and the aetio-
logical factors and pathogenesis of this potentially lethal
complication discussed. Guidelines fo! the safe use of hexo-
prenaline in preterm labour are suggested.
S Afr Med J 1991; 79: 620-622.
Complications associ~ted with the use of j:l-sympathomimetic
agents in preterm labour have been reviewed by Benederti. 1
Pulmonary oedema, myocardial ischaemia, cardiac arrhythmia,
cerebral vasospasm, hypotension, hyperglycaemia and hypo-
kalaemia have all been reponed.
Pulmonary oedema is an adverse reaction unique to the
parturient patient and has been reponed with most of the
commonly used tocolytic agents, including ritodrine,2 terbuta-
line3 and salbutamol.4 No cases of pulmonary oedema associated
with the use of hexoprenaline in preterm labour have, to our
knowledge, been reponed.
We repon 4 cases of pulmonary oedema in patients who
received hexoprenaline with or without corticosteroids and!or
indomethacin for preterm labour.
Case reports
Case 1
A 25-year-old primigravid woman with a previously uncom-
plicated twin pregnancy was admitted to hospital in labour at
32 weeks' gestation.
The patient had no previous history of cardiovascular disease
o·r serious illness. The arterial blood pressure was 120/80
mmHg on admission and the heart rate 72/tnin. Auscultation
of lungs and hean revealed no abnormality and the jugular
venous pressure was not elevated. The cervix was 3 cm
dilated, well effaced and the membranes were intact. The
presenting part of the leading twin was cephalic, at the level of
the ischial spines. The fetal heart rates were normal. Contrac-
tions were fairly strong and 3 - 4 minutes apart. The haemo-
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globin level was 13,3 g/dl and the leucocyte count 13,8 X
109/1. There was no clinical evidence of chorio-amnionitis.
An infusion of hexoprenaline was started. A dose of 1,20
JIg/min was required to suppress iIterine action. The pulse
rate varied between 95 and l20/tnin. Betamethasone 12 mg
was administered to accelerate fetal lung maturity and repeated
12 hours later. After 72 hours of treatment the patient com-
plained of tightness of the chest and shortness of breath. On
examination she was tachypnoeic with a respiratory rate of
24/min, centrally cyanosed, coughing and pyrexial (37,8°C).
The blood pressure was 160/100 mmHg and the pulse rate
130/min and regular. Early inspiratory crepitations could be
heard at both lung bases. Arterial partial pressure of oxygen
(PaD2) was 45,8 mmHg, arterial carbon dioxide tension
(PacD2) 20,8 mmHg and the pH 7,47. Chest radiography
showed features of pulmonary oedema. The ECG was normal,
apan from a sinus tachycardia. A positive fluid balance of
3700 ml was recorded over the 72-hour period.
Oxygen was administered (4 l/min by face mask). The
hexoprenaline infusion was discontinued and furosemide 40
mg was given intravenously. The PaD2 improved only slightly
to 54,S mmHg despite the supplementary oxygen administra-
tion.
Artificial -rupture of the membranes was performed and 2
hours later the ftrst twin was delivered with Anderson,'s forceps.
The second infant was delivered by assisted breech delivery
with forceps to the aftercoming head. The first infant weighed
1800 g and had Apgar scores of 9 and 10. The second infant
weighed 1280 g and the Apgar scores were 7 and 9.
Immediately after delivery the patient was transferred to the
intensive care unit where endotracheal inrubation and assisted
ventilation were commenced.
After 6 hours, ventilatory and gas exchange function
improved and the patient was weaned to spontaneous venti-
lation with constant positIve airway pressure. She was success-
fully exrubated on the 3rd post-parrum day and discharged
well on the 10th post-parrum day.
Cases 2, 3 and 4
To avoid repetition, the salient fearures of all 4 cases are
listed in Table I. The ages of the patients varied from 20 years
to 36 years and the period ofgestation was between 28 lUld 32
weeks.
None of the patients had any evidence of au:diovascular
disease before or on admission to hospital. ,
Patients 1 and 3 had twin pregnancies. The membranes
were intact in all 4 patients and although patient 4 had
pyelonephritis, there was no evidence of chorio-amnionitis in
any mother. We do not use tocolysis in patients with evidence
of chorio-amnionitis, or abruptio placentae, and rarely in those
with ruptured membranes.
On initiation of tocolysis, hexoprenaline 10 JIg is· given
slowly intravenously followed by a titration of 300 JIg in 1 litre
of normal saline at the lowest rate to suppress uterine activity
but not to induce a maternal tachycardia above l20/min. This
procedure was followed in each of the 4 cases and the concen-
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TABLE I. SUMMARY OF SALIENT FEATURES OF ALL 4 CASES
Case 1" Case 2 Case 3" Case 4
Age (yrs) 25 29 20 36
Gestation (wks) 32 30 29 28
Slood pressure and pulse rate on admission 120/80;72 110nO;88 110/65;98 115/70;108
(temp. 39°)
chest radiograph on admission Clear Clear Clear Clear
Heart, on admission NAD NAD NAD NAD
cervical dilatation on admission (cm) 3 1 (cerv. cerclage) 2 2,5 '
Membranes, on admission Intact Intact Intact Intact
cltorio-amnionitis, on admission No No No Pyelonephritis
FiJI! blood count and U&E Normal Normal Normal Normal
•
DOse of hexoprenaline (JLg/min) 1 - 1,20 0,5 - 1,20 0,5 - 1 0,5 - 1
setamethasone (mg) 12 x 2 12 x 2 12 x 2 No
Indomethacin (g) No 1 x 2 1 x 2 No
Tocolysis - pulmonary oedema interval (h) 72 28 56 52
Initial Pao, 45,8 70 58,2 68,4
Initial Paco, 20,8 40 32,4 40
Cltest radiography Pulm. oedema Pulm. oedema Pulm. oedema Pulm. oedema
ECG Normal Normal Normal Normal
positive fluid balance/24 h 1233 640 780 450
Furosemide (mg) 40 x 3 40 x 2 20 x 2 20 x 1
Delivery Forceps x 2 C/S Vaginal Vaginal
Weight (g) 1800 1500 650 1240
1280 780
Assisted ventilation Yes (72 h) No No No
Discharge day 10 7 7 8
• Twin
I
tration of hexoprenaline infused varied between 0,5 J.lg and
1,20 J.lg/min.
Betamethasone 12 mg intramuscularly was given to the first
3 patients on admission and repeated 12 hours later to accele-
rate fetal lung maturity. Indomethacin was given to patients 2
and 3. This should not exceed 2 g124 h and is commonly used
by two of the authors.
All 4 patients developed dyspnoea, tachypnoea, bilateral
basal crepitations and evidence of pulmonary oedema on chest
radiography but all had normal ECGs. No significant hypo-
tension or electrolyte disturbance occurred in any of the 4
patients.
The interval from starting hexoprenaline to the time of
developing pulmonary oedema varied from 25 hours to 72
hours (average 52 hours).
All patients had a positive fluid balance, the highest positive
balance occurring in patient 1 who required assisted ventilation.
Furosemide 20 - 80 mg was given to initiate a diuresis in all
patients. A caesarean section for breech presentation was
performed in patient 2. Both twin infants of patient 3 died of
severe hyaline membrane disease. The other infants all survived
after treatment for mild to moderately severe hyaline membrane
disease.
Discussion
PUlmonary oedema as a complication of tb-sympathomimetic
treatment to inhibit preterm labour was first reported in
1977.5 Despite a reported frequency of 5% for this potentially
fatal complication6 there appears to be limited appreciation of
the need for cardiovascular monitoring in the mother. Maternal
mortality for this complication is in the order of 5 -lO%Y
The pathogenesis of pulmonary oedema associated with
tocolytic therapy remains unclear., Cardiac failure does not
appear to be the cause of the pulmonary oedema.9
During pregnancy there is an increase in pulmonary capillary
permeability associated with a decreased plasma oncotic pres-
sure, which results in an increase in total lung water. lO Beta-
sympathomimetic agents appear to increase the alveolar-capil-
lary permeability allowing more fluid into the interstitial lung
tissue:,9,11 although this is not accepted' by all authors. 12
In addition, l3-adrenergic agonists affect total body water
balance by stimulating the renin-aldosterone system and releas-
ing antidiuretic hormone, producing an increase in plasma
volume and a fall in both haematocrit and colloid osmotic
pressure. 1l These effects are most pronounced when isotonic
saline solutions are used, resulting in expansion of the plasma
volume, producing pulmonary congestion and, in some cases,
pulmonary oedema.
Fluid retention due to corticosteroid administration may be
important, although betamethasone and dexamethasone have
minimal mineralocorticoid activity.
Indomethacin may contribute to sodium and water retention
and also affect capillary permeability, although its role in this
respect in pregnant women is not clear. 14
Multiple pregnancy is associated with a greater increase in
plasma volume than occurs in singleton pregnancy and is thus
predisposed not only to preterm labour, but also to the
development of pulmonary oedema when tocolytic agents are
used. Two of our 4 cases were in twin pregnancies.
Iatrogenic overload, especially with prolonged intravenous
administration of fluids is another contributing factor and in
all 4 of our patients a positive fluid balance was recorded, the
highest in the most severely affected patient.
In view of our experience, we have instituted guidelines for
the use of hexoprenalIDe tocolysis in preterm labour. On
admission to hospital patients with underlying heart disease or
evidence of heart disease on ECG examination are excluded
from tocolytic therapy with hexoprenaline. Similarly, clinical,
biochemical or amniocentesis evidence of chorio-amnionitis
excludes patients from tocolysis. In the presence of maternal
infection, the risk of pulmonary oedema from tocolytic therapy
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is greatly increased. 15,16 If fetal breathing movements are
observed on ultrasonography tocolysis is probably not required.
Infusion of hexoprenaline is by titration using 300 J-Lg in 1
litre of half dextrose/saline solution until uterine contractions
cease but not exceeding 1,20 J-Lg/min or a maternal pulse rate
of 120/min. Intravenous fluid intake is restricted to 125 ml/h
and may necessitate doubling the concentration of the hexo-
prenaline solution. Blood pressure, pulse, temperature, respira-
tion and intake and output are measured hourly. Regular
auscultation of the lung bases is performed and if dyspnoea or
any signs of pulmonary oedema develop, tocolysis is stopped,
blood gases are measured and chest radiography performed.
Restarting tocolysis is only considered after careful evaluation
of the patient.
The maximum period for which tocolysis is used is 48
hours.
The value of ,B-sympathomimetic agents appears to be
twofold. Firstly, they allow patients to be transferred to hos-
pitals with high-care facilities for the premature infant.
Secondly, they allow the administration of corticosteroids
where appropriate to enhance fetal lung maturity. Beyond this,
there seems very linle evidence that sympathomimetic agents
will be of benefit in preterm labour. Although randomised
clinical trials with ,B-sympathomimetic agents have produced
contradictory results, the majority of well-controlled ran-
domised studies do riot show significant prolongation of preg-
nancy or a significant modification of the ultimate perinatal
outcome. II,l7
It would thus seem that beyond 48 hours any possible
benefit will be outweighed by the risks of prolonged use of
,B-sympathomimetic agents for tocolysis in preterm labour.
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